Biotech Hangout’s Post

Interested in learning more about the growing role of data #digitalisation in the #advancedtherapies industry? Join Jacqueline Barry at The Scotsman Life Sciences Conference 2023 on the 29th November where she will be chairing a panel on 'Data and Digitalisation' which will address the role of digitalisation and data usage in the supply chain for cell and gene therapies, AI innovation, compound discovery and drug development. Learn more and register: https://buff.ly/3PYgtnw #celltherapies #genetherapies #datadigitalisation #lifesciences

That's a wrap at #ATW24! Stimulating sessions ignited meaningful discussions on navigating cell and gene therapy manufacturing challenges. We also unveiled our Sefia Select system, the latest addition to our autologous #CAR T #celltherapy manufacturing workflow — three crucial steps, all within one outstanding system! Scaling CAR T commercially can present challenges, like batch failures and high manufacturing costs. That's where the Sefia Select system steps in, allowing you to manufacture at a commercial scale. Designed as a closed solution that's automated and digitally integrated, the system efficiently manages cell isolation, harvest, and formulation steps. Learn how this system can help automate your workflow: https://lnkd.in/eAR4PR6c #cellandgenetherapy

The November issue of Life Science Leader is out! Krish Krishnan and Suma Krishnan of (Pittsburgh-based) Krystal Biotech, Inc. are on the cover, sharing details of their journey to bring the first topical, redosable gene therapy to market. Sath Shukla talks about Spero Therapeutics' business model for novel antibiotics, Wayne Koberstein covers Freya Biosciences in 'Companies To Watch,' and more: https://lnkd.in/gggauDAb.

That's a wrap at Phacilitate #ATW24! Stimulating sessions ignited meaningful discussions on navigating cell and gene therapy manufacturing challenges. We also unveiled our Sefia Select system, the latest addition to our autologous #CAR T #celltherapy manufacturing workflow — three crucial steps, all within one outstanding system! Scaling CAR T commercially can present challenges, like batch failures and high manufacturing costs. That's where the Sefia Select system steps in, allowing you to manufacture at a commercial scale. Designed as a closed solution that's automated and digitally integrated, the system efficiently manages cell isolation, harvest, and formulation steps. #cellandgenetherapy

Uncovers the complex interplay of Alliance, Acquisition, and Financing. Witness the exploration of the forces shaping the future of healthcare, where collaboration, strategic moves, and financial backing converge to drive the evolution of gene, cell, and RNA therapies. #HealthTech #HealthcareXchange #MedicalResearch #ScienceAlliance #HealthcareInvestment #PharmaAcquisition #CellTherapy #GeneTherapy #FinancingHealth #IndustryLeadership

That's a wrap at #ATW24! Stimulating sessions ignited meaningful discussions on navigating cell and gene therapy manufacturing challenges. We also unveiled our Sefia Select system, the latest addition to our autologous #CAR T #celltherapy manufacturing workflow — three crucial steps, all within one outstanding system! Scaling CAR T commercially can present challenges, like batch failures and high manufacturing costs. That's where the Sefia Select system steps in, allowing you to manufacture at a commercial scale. Designed as a closed solution that's automated and digitally integrated, the system efficiently manages cell isolation, harvest, and formulation steps. Learn how this system can help automate your workflow: https://lnkd.in/ekkMJY6R #cellandgenetherapy

Biocom California recently invited Sapient to contribute an article for its Lifelines Magazine edition focused on innovations in #genetherapy and #celltherapy. https://bit.ly/3KbQEOm While cell- and gene-based treatments are advancing rapidly, spurred by a landmark year of FDA approvals, their development is not without challenges. We discuss how #multiomics for gene and cell therapy can deliver the novel insights needed to realize the incredible therapeutic potential represented in these pipelines today: https://bit.ly/3KbQEOm

That's a wrap at #ATW24! Stimulating sessions ignited meaningful discussions on navigating cell and gene therapy manufacturing challenges. We also unveiled our Sefia Select system, the latest addition to our autologous #CAR T #celltherapy manufacturing workflow — three crucial steps, all within one outstanding system! Scaling CAR T commercially can present challenges, like batch failures and high manufacturing costs. That's where the Sefia Select system steps in, allowing you to manufacture at a commercial scale. Designed as a closed solution that's automated and digitally integrated, the system efficiently manages cell isolation, harvest, and formulation steps. Learn how this system can help automate your workflow: https://lnkd.in/emNHjTAq #cellandgenetherapy

When industry and academic partners team up with ElevateBio, they have complete access to our next-generation cell and gene therapy discovery, development, manufacturing, and commercialization processes and technologies. Together, we can bring critical, potentially lifesaving medicines forward faster. Learn more about how we can accelerate your product lifecycle at elevate.bio/partnering. #Biotech #BiotechPartnership #InnovateAtElevate

Think ahead: preparing for challenges to accelerate your #celltherapycommercialization Later this month, Saba Ghassemi (Assistant Professor, Center for Cellular Immunotherapies, University of Pennsylvania), Sabrina Carmichael (Fast Trak Global Technical Leader, Cytiva), Hannah Song (Biologist, Product Development, NIH Center for Cellular Engineering), and Kathryn Henckels (Associate Director, Cell & Gene Therapy API, Johnson & Johnson) will discuss how decisions made during the early stages of process development can have long-lasting effects. Attend this webinar to learn about: • Establishing a cost-effective and reliable manufacturing process • The benefits of implementing the appropriate closed and automated process during early clinical trials • Critical factors necessary for the successful commercialization of an advanced therapy Register for this #webinar below: